Skip to content

Search

RHINO

RHINO researchers from The Kids' Wal-yan Respiratory Research Centre, will analyse ORIGINS data and turn it into meaningful respiratory and allergy outcome data that can be used by researchers around the world.

Happy Parenting Program

The Happy Parenting Program is investigating new ways to provide support to parents with young children from an early age.

Screen ORIGINS

Understanding how families engage with screen technologies and how it may influence child development

Childhood Leukaemia

Assessing efficacy of infant T-cells to develop child-specific cancer immunotherapies.

The Dental Screening Study

Assessing a dental photographic method as an alternative dental screening method.

Medical History & Conditions

The impact of familial and childhood health conditions on health later in life.

The Impact of ORIGINS

The impact of ground-breaking research is helping ORIGINS families

The impact a Mediterranean Diet in the third trimester of pregnancy has on neonatal body fat percentage

Maternal diet during pregnancy has long been recognised as an important determinant of neonatal outcomes and child development. Infant body composition is a potentially modifiable risk factor for predicting future health and metabolic disease.

“Coronavirus Changed the Rules on Everything”: Parent Perspectives on How the COVID‐19 Pandemic Influenced Family Routines, Relationships and Technology Use in Families with Infants

This study explores how the first wave of the COVID‐19 pandemic influenced family routines, relationships and technology use (smartphones and tablet computers) among families with infants. Infancy is known to be an important period for attachment security and future child development, and a time of being susceptible to changes within and outside of the family unit.

Earth dreams: Reimagining ARPA for health of people, places and planet

Bold new approaches are urgently needed to overcome global health challenges. The proposed Advanced Research Projects Agency for Health (ARPA-H) is intended to provide rapid health breakthroughs.